Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Atrion Corporation stock | $640.5

Own Atrion Corporation stock in just a few minutes.

Fact checked

Atrion Corporation is a medical instruments & supplies business based in the US. Atrion Corporation shares (ATRI) are listed on the NASDAQ and all prices are listed in US Dollars. Atrion Corporation employs 616 staff and has a trailing 12-month revenue of around USD$149.8 million.

How to buy shares in Atrion Corporation

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Atrion Corporation. Find the stock by name or ticker symbol: ATRI. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Atrion Corporation reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$640.5, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Atrion Corporation, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Atrion Corporation. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Atrion Corporation share price

Use our graph to track the performance of ATRI stocks over time.

Atrion Corporation shares at a glance

Information last updated 2020-12-26.
Latest market closeUSD$640.5
52-week rangeUSD$565.3308 - USD$748.9121
50-day moving average USD$610.2288
200-day moving average USD$634.8613
Wall St. target priceUSD$300
PE ratio 35.4955
Dividend yield USD$7 (1.11%)
Earnings per share (TTM) USD$17.749

Buy Atrion Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
$0
Stocks, Forex
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Public
$0
Stocks, ETFs
N/A
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Atrion Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Atrion Corporation price performance over time

Historical closes compared with the close of $640.5 from 2020-12-18

1 week (2021-01-15) -12.74%
1 month (2020-12-23) 1.99%
3 months (2020-10-22) -4.39%
6 months (2020-07-22) 1.34%
1 year (2020-01-22) -14.39%
2 years (2019-01-22) -16.82%
3 years (2018-01-22) 5.19%
5 years (2016-01-22) 72.36%

Is Atrion Corporation under- or over-valued?

Valuing Atrion Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Atrion Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Atrion Corporation's P/E ratio

Atrion Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 35x. In other words, Atrion Corporation shares trade at around 35x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Atrion Corporation's EBITDA

Atrion Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$48.8 million.

The EBITDA is a measure of a Atrion Corporation's overall financial performance and is widely used to measure a its profitability.

Atrion Corporation financials

Revenue TTM USD$149.8 million
Operating margin TTM 24.98%
Gross profit TTM USD$70.7 million
Return on assets TTM 9%
Return on equity TTM 13.95%
Profit margin 21.9%
Book value $130.19
Market capitalisation USD$1.2 billion

TTM: trailing 12 months

Shorting Atrion Corporation shares

There are currently 52,707 Atrion Corporation shares held short by investors – that's known as Atrion Corporation's "short interest". This figure is 1.5% up from 51,935 last month.

There are a few different ways that this level of interest in shorting Atrion Corporation shares can be evaluated.

Atrion Corporation's "short interest ratio" (SIR)

Atrion Corporation's "short interest ratio" (SIR) is the quantity of Atrion Corporation shares currently shorted divided by the average quantity of Atrion Corporation shares traded daily (recently around 7949.7737556561). Atrion Corporation's SIR currently stands at 6.63. In other words for every 100,000 Atrion Corporation shares traded daily on the market, roughly 6630 shares are currently held short.

However Atrion Corporation's short interest can also be evaluated against the total number of Atrion Corporation shares, or, against the total number of tradable Atrion Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Atrion Corporation's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Atrion Corporation shares in existence, roughly 30 shares are currently held short) or 0.0417% of the tradable shares (for every 100,000 tradable Atrion Corporation shares, roughly 42 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Atrion Corporation.

Find out more about how you can short Atrion Corporation stock.

Atrion Corporation share dividends

38%

Dividend payout ratio: 38% of net profits

Recently Atrion Corporation has paid out, on average, around 38% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.11% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Atrion Corporation shareholders could enjoy a 1.11% return on their shares, in the form of dividend payments. In Atrion Corporation's case, that would currently equate to about $7 per share.

While Atrion Corporation's payout ratio might seem fairly standard, it's worth remembering that Atrion Corporation may be investing much of the rest of its net profits in future growth.

Atrion Corporation's most recent dividend payout was on 15 December 2020. The latest dividend was paid out to all shareholders who bought their shares by 30 November 2020 (the "ex-dividend date").

Have Atrion Corporation's shares ever split?

Atrion Corporation's shares were split on a 3:2 basis on 3 December 1996. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Atrion Corporation shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Atrion Corporation shares which in turn could have impacted Atrion Corporation's share price.

Atrion Corporation share price volatility

Over the last 12 months, Atrion Corporation's shares have ranged in value from as little as $565.3308 up to $748.9121. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Atrion Corporation's is 0.1402. This would suggest that Atrion Corporation's shares are less volatile than average (for this exchange).

Atrion Corporation overview

Atrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Germany, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise MPS2 Myocardial Protection System that delivers fluids and medications, mixes critical drugs, and controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and a line of products designed for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; one-way and two-way pressure relief valves that protect sensitive electronics; and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales personnel, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site